Novel cell therapy treatments offer promise to immune-compromised children In a first-of-its-kind clinical trial, researchers found that intravenous therapies made from virus-specific T-cells (VST) can effectively treat immunocompromised pediatric patients, far surpassing the current standard of care, according to new research published in Nature Communications.
https://medicalxpress.com/news..../2024-04-cell-therap